These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 10091699)

  • 1. Inhibition of herpes proteases and antiviral activity of 2-substituted thieno[2,3-d]oxazinones.
    Jarvest RL; Pinto IL; Ashman SM; Dabrowski CE; Fernandez AV; Jennings LJ; Lavery P; Tew DG
    Bioorg Med Chem Lett; 1999 Feb; 9(3):443-8. PubMed ID: 10091699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of human cytomegalovirus protease by enedione derivatives of thieno[2,3-d]oxazinones through a novel dual acylation/alkylation mechanism.
    Pinto IL; Jarvest RL; Clarke B; Dabrowski CE; Fenwick A; Gorczyca MM; Jennings LJ; Lavery P; Sternberg EJ; Tew DG; West A
    Bioorg Med Chem Lett; 1999 Feb; 9(3):449-52. PubMed ID: 10091700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The herpesvirus protease: mechanistic studies and discovery of inhibitors of the human cytomegalovirus protease.
    Flynn DL; Becker DP; Dilworth VM; Highkin MK; Hippenmeyer PJ; Houseman KA; Levine LM; Li M; Moormann AE; Rankin A; Toth MV; Villamil CI; Wittwer AJ; Holwerda BC
    Drug Des Discov; 1997 May; 15(1):3-15. PubMed ID: 9332827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiviral drug discovery targeting to viral proteases.
    Hsu JT; Wang HC; Chen GW; Shih SR
    Curr Pharm Des; 2006; 12(11):1301-14. PubMed ID: 16611117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis of thieno[2,3-d]oxazines and thieno[2,3-d]thiazines as subtype specific kainate receptor antagonists.
    Briel D; Rybak A; Mann S; Kronbach C; Unverferth K
    Curr Med Chem; 2009; 16(35):4704-11. PubMed ID: 19903139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The herpesvirus proteases as targets for antiviral chemotherapy.
    Waxman L; Darke PL
    Antivir Chem Chemother; 2000 Jan; 11(1):1-22. PubMed ID: 10693650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective nonpeptidic inhibitors of herpes simplex virus type 1 and human cytomegalovirus proteases.
    Matsumoto M; Misawa S; Chiba N; Takaku H; Hayashi H
    Biol Pharm Bull; 2001 Mar; 24(3):236-41. PubMed ID: 11256477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-nucleoside inhibitors of herpesviruses.
    Wathen MW
    Rev Med Virol; 2002; 12(3):167-78. PubMed ID: 11987142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Computational Studies of Benzoxazinone Derivatives as Antiviral Agents against Herpes Virus Type 1 Protease.
    Mello JF; Botelho NC; Souza AM; Oliveira R; Brito MA; Abrahim-Vieira Bde A; Sodero AC; Castro HC; Cabral LM; Miceli LA; Rodrigues CR
    Molecules; 2015 Jun; 20(6):10689-704. PubMed ID: 26065834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Arylcyanoacrylamides as inhibitors of the Dengue and West Nile virus proteases.
    Nitsche C; Steuer C; Klein CD
    Bioorg Med Chem; 2011 Dec; 19(24):7318-37. PubMed ID: 22094280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bicyclic anti-VZV nucleosides: Thieno analogues retain full antiviral activity.
    Brancale A; McGuigan C; Algain B; Savy P; Benhida R; Fourrey JL; Andrei G; Snoeck R; De Clercq E; Balzarini J
    Bioorg Med Chem Lett; 2001 Sep; 11(18):2507-10. PubMed ID: 11549457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The design and development of 2-aryl-2-hydroxy ethylamine substituted 1H,7H-pyrido[1,2,3-de]quinoxaline-6-carboxamides as inhibitors of human cytomegalovirus polymerase.
    Tanis SP; Strohbach JW; Parker TT; Moon MW; Thaisrivongs S; Perrault WR; Hopkins TA; Knechtel ML; Oien NL; Wieber JL; Stephanski KJ; Wathen MW
    Bioorg Med Chem Lett; 2010 Mar; 20(6):1994-2000. PubMed ID: 20167488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 2-Substituted benzoxazinone analogues as anti-human coronavirus (anti-HCoV) and ICAM-1 expression inhibition agents.
    Hsieh PW; Chang FR; Chang CH; Cheng PW; Chiang LC; Zeng FL; Lin KH; Wu YC
    Bioorg Med Chem Lett; 2004 Sep; 14(18):4751-4. PubMed ID: 15324901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. (D)- and (L)-cyclohexenyl-G, a new class of antiviral agents: synthesis, conformational analysis, molecular modeling, and biological activity.
    Wang J; Froeyen M; Hendrix C; Andrei C; Snoeck R; Lescrinier E; De Clercq E; Herdewijn P
    Nucleosides Nucleotides Nucleic Acids; 2001; 20(4-7):727-30. PubMed ID: 11563102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenylalanine and Phenylglycine Analogues as Arginine Mimetics in Dengue Protease Inhibitors.
    Weigel LF; Nitsche C; Graf D; Bartenschlager R; Klein CD
    J Med Chem; 2015 Oct; 58(19):7719-33. PubMed ID: 26367391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and antiviral activity of HCV NS3/4A peptidomimetic boronic acid inhibitors.
    Boloor A; Hanway D; Joshi M; Winn DT; Mendez G; Walls M; Wei P; Qian F; Zhang X; Zhang Y; Hepperle ME; Li X; Campbell DA; Betancort JM
    Bioorg Med Chem Lett; 2009 Oct; 19(19):5708-11. PubMed ID: 19713109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pyrrolidine-5,5-trans-lactams as novel mechanism-based inhibitors of human cytomegalovirus protease. Part 3: potency and plasma stability.
    Borthwick AD; Exall AM; Haley TM; Jackson DL; Mason AM; Weingarten GG
    Bioorg Med Chem Lett; 2002 Jul; 12(13):1719-22. PubMed ID: 12067545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemotherapy of varicella-zoster virus by a novel class of highly specific anti-VZV bicyclic pyrimidine nucleosides.
    Balzarini J; McGuigan C
    Biochim Biophys Acta; 2002 Jul; 1587(2-3):287-95. PubMed ID: 12084470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-herpesvirus activities and cytotoxicities of 2-thiopyrimidine nucleoside analogues in vitro.
    Shigeta S; Mori S; Kira T; Takahashi K; Kodama E; Konno K; Nagata T; Kato H; Wakayama T; Koike N; Saneyoshi M
    Antivir Chem Chemother; 1999 Jul; 10(4):195-209. PubMed ID: 10480738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potent HIV-1 protease inhibitors with antiviral activities in vitro.
    Sham HL; Betebenner DA; Wideburg NE; Saldivar AC; Kohlbrenner WE; Vasavanonda S; Kempf DJ; Norbeck DW; Zhao C; Clement JJ
    Biochem Biophys Res Commun; 1991 Mar; 175(3):914-9. PubMed ID: 2025263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.